Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?

Nature Clinical Practice Oncology volume 4, pages 564–565 (2007)Cite this article

boxed-textZheng Z et al. (2007) DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 356: 800–808

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Olaussen KA et al. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355: 983–991

    Article  CAS  Google Scholar 

  2. Potti A et al. (2006) A genomic strategy to refine prognosis in early stage non-small cell lung cancer. N Engl J Med 355: 570–580

    Article  CAS  Google Scholar 

  3. Chen HY et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11–20

    Article  CAS  Google Scholar 

  4. Bepler G et al. (2006) RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small cell lung cancer. J Clin Oncol 24: 4731–4737

    Article  CAS  Google Scholar 

  5. Rosell R et al. (2005) ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p) [abstract #7002]. J Clin Oncol 23 (Suppl 16S part I)

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. RS Heist is a Medical Oncologist at the Massachusetts General Hospital Cancer Center, Boston, MA, USA,

    Rebecca S Heist

  2. G Liu is the Alan B Brown Chair in Molecular Genomics at Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada, and a Doris Duke Clinician Scientist at the Harvard School of Public Health, Boston, MA,

    Geoffrey Liu

  3. W Zhou is a Senior Epidemiologist at the Merck Research Laboratories, North Wales, PA, and a Research Scientist at the Harvard School of Public Health, Boston, MA, USA.,

    Wei Zhou

Authors
  1. Rebecca S Heist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geoffrey Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Zhou.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heist, R., Liu, G. & Zhou, W. Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?. Nat Rev Clin Oncol 4, 564–565 (2007). https://doi.org/10.1038/ncponc0909

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0909

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing